Crystal structure of (3E,5E)-3,5-bis(3-nitrobenzylidene)-1-((4-(trifluoromethyl)phenyl)sulfonyl)piperidin-4-one - dichloromethane (2/1), C53H38Cl2F6N6O14S2

被引:9
作者
Sun, Yue [1 ]
Wang, Shu-Xia [2 ]
Hou, Gui-Ge [1 ]
机构
[1] Binzhou Med Univ, Sch Pharm, Key Lab Prescript Effect & Clin Evaluat, State Adm Tradit Chinese Med China, Yantai 264003, Peoples R China
[2] Zhucheng Peoples Hosp, Dept Ultrasonog, Zhucheng 262200, Peoples R China
来源
ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES | 2019年 / 234卷 / 05期
基金
中国国家自然科学基金;
关键词
AGENTS; 3,5-BIS(ARYLIDENE)-4-PIPERIDONES; DERIVATIVES;
D O I
10.1515/ncrs-2019-0253
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
C53H38Cl2F6N6O14S2, triclinic, P (1) over bar (no. 2), a =12.1975(6) angstrom, b = 13.9973(7) angstrom, c = 16.3818(10) angstrom, alpha = 69.365(5)degrees, beta = 76.620(5)degrees, gamma = 77.292(4)degrees, V = 2516.8(3) angstrom(3), Z = 2, R-gt (F) = 0.0540, wR(ref)(F-2)= 0.1413, T = 100.02(10) K.
引用
收藏
页码:1047 / 1049
页数:3
相关论文
共 12 条
  • [1] Synthesis, crystal structures and anti-inflammatory activity of four 3,5-bis(arylidene)-N-benzenesulfonyl-4-piperidone derivatives
    Li, Ning
    Bai, Xianyong
    Zhang, Lianshuang
    Hou, Yun
    [J]. ACTA CRYSTALLOGRAPHICA SECTION C-STRUCTURAL CHEMISTRY, 2018, 74 : 1171 - +
  • [2] N-phenylsulfony1-3,5-bis(arylidene)-4-piperidone derivatives as activation NF-κB inhibitors in hepatic carcinoma cell lines
    Li, Ning
    Xin, Wen-Yu
    Yao, Bin-Rong
    Cong, Wei
    Wang, Chun-Hua
    Hou, Gui-Ge
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 155 : 531 - 544
  • [3] Novel dissymmetric 3,5-bis(arylidene)-4-piperidones as potential antitumor agents with biological evaluation in vitro and in vivo
    Li, Ning
    Xin, Wen-Yu
    Yao, Bin-Rong
    Wang, Chun-Hua
    Cong, Wei
    Zhao, Feng
    Li, Hong-Juan
    Hou, Yun
    Meng, Qing-Guo
    Hou, Gui-Ge
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 147 : 21 - 33
  • [4] Li X. Y., 2019, Z KRIST-NEW CRYST ST, P771
  • [5] Crystal structure of 4-((E)-((E)-5-(2-fluorobenzylidene)-1-((4-fluorophenyl) sulfonyl)-4-oxopiperidin-3-ylidene)methyl)benzonitrile, C26H18F2N2O3S
    Liu, Lian-Dong
    Liu, Shu-Lian
    Hou, Gui-Ge
    [J]. ZEITSCHRIFT FUR KRISTALLOGRAPHIE-NEW CRYSTAL STRUCTURES, 2018, 233 (06): : 1063 - 1065
  • [6] The Essential Medicinal Chemistry of Curcumin
    Nelson, Kathryn M.
    Dahlin, Jayme L.
    Bisson, Jonathan
    Graham, James
    Pauli, Guido F.
    Walters, Michael A.
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (05) : 1620 - 1637
  • [7] Rigaku O. D., 2017, CrysAlisPRO
  • [8] A short history of SHELX
    Sheldrick, George M.
    [J]. ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES, 2008, 64 : 112 - 122
  • [9] Sheldrick GM, 2015, ACTA CRYSTALLOGR C, V71, P3, DOI [10.1107/S2053229614024218, 10.1107/S0108767307043930, 10.1107/S2053273314026370]
  • [10] Dissymmetric pyridyl-substituted 3,5-bis(arylidene)-4-piperidones as anti-hepatoma agents by inhibiting NF-κB pathway activation
    Yao, Bin-Rong
    Sun, Yue
    Chen, Shuang-Long
    Suo, Hao-Dong
    Zhang, Yu -Long
    Wei, Hao
    Wang, Chun-Hua
    Zhao, Feng
    Cong, Wei
    Xin, Wen-Yu
    Hou, Gui-Ge
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2019, 167 : 187 - 199